Skip to content

Acute Eosinophilic Myocarditis International Registry

Acute Eosinophilic Myocarditis International Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06447935
Enrollment
100
Registered
2024-06-07
Start date
2021-11-16
Completion date
2024-05-27
Last updated
2024-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocarditis

Keywords

Eosinophilic Myocarditis, Endomyocardial Biopsy

Brief summary

Retrospective collection of clinical, histological, imaging data regarding patients with acute histologically-proven eosinophilic myocarditis.

Detailed description

Eosinophilic myocarditis (EM) is an acute life-threatening inflammatory disease of the heart. We collect clinical, histologic, laboratory, diagnostic and imaging data regarding acute EM with a histological diagnosis and symptoms onset within 30 days from first medical contact from hospitals around the world. The main objective is to investigate and describe clinical presentation, main systemic conditions associated and outcomes of the first series of patients with acute myocarditis and histological evidence of eosinophilic infiltration within myocardium.

Interventions

OTHERNo intervention

not applicable - no intervention required

Sponsors

Niguarda Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Patients with histological diagnosis gained during an hospitalization within 30 days from symptoms onset.

Design outcomes

Primary

MeasureTime frameDescription
Natural History of Eosinophilic Myocarditis3 yearProportion of patients who die or need a heart transplantation from index admission.

Secondary

MeasureTime frameDescription
Natural History of Eosinophilic Myocarditis subgroups based on etiology3 yearsProportion of patients who die or need a heart transplantation from index admission dividing patients based on the underlying condition (for instance idiopathic, hypersensitivity, eosinophilic granulomatosis with polyangiitis,…)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026